ArticleJournal of vision2016
The risk of pedestrian collisions with peripheral visual field loss.
Article in Journal of vision, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Effect of peripheral field loss on gait performance: a systematic review and meta-analysis.Frontiers in neuroscience · 2025Pooled it
- Boosting hemianopia recovery: the power of interareal cross-frequency brain stimulation.Brain : a journal of neurology · 2025Trial
- Efficacy of a wearable night-vision aid in patients with concentric peripheral visual field loss: a randomized, crossover trial.Japanese journal of ophthalmology · 2024Trial
- Development and psychometric validation of a novel, self-report visual processing questionnaire (ViPro-SR) for neurodivergent adults.Current psychology (New Brunswick, N.J.) · 2026Article
- Managing Retinitis Pigmentosa: A Literature Review of Current Non-Surgical Approaches.Journal of clinical medicine · 2025Review
- Gaze Scanning on Mid-Block Sidewalks by Pedestrians With Homonymous Hemianopia With or Without Spatial Neglect.Investigative ophthalmology & visual science · 2024Article
- Review: Binocular double vision in the presence of visual field loss.Journal of vision · 2024Review
- Pilot study of a pedestrian collision detection test for a multisite trial of field expansion devices for hemianopia.Optometry and vision science : official publication of the American Academy of Optometry · 2024Article
- Understanding viewpoint changes in peripheral prisms for field expansion by virtual reality simulation.Biomedical optics express · 2024Article
- Egocentric Boundaries on Distinguishing Colliding and Non-Colliding Pedestrians while Walking in a Virtual Environment.IS&T International Symposium on Electronic Imaging · 2024Article
- Oblique multi-periscopic prism for field expansion of homonymous hemianopia.Biomedical optics express · 2023Article
- Optimization and Validation of a Virtual Reality Orientation and Mobility Test for Inherited Retinal Degenerations.Translational vision science & technology · 2023Article
- Influence of Systematic Gaze Patterns in Navigation and Search Tasks with Simulated Retinitis Pigmentosa.Brain sciences · 2021Article
- A Virtual Reality Orientation and Mobility Test for Inherited Retinal Degenerations: Testing a Proof-of-Concept After Gene Therapy.Clinical ophthalmology (Auckland, N.Z.) · 2021Article
- 2017 Charles F. Prentice Award Lecture: Peripheral Prisms for Visual Field Expansion: A Translational Journey.Optometry and vision science : official publication of the American Academy of Optometry · 2020Article
- Multi-periscopic prism device for field expansion.Biomedical optics express · 2020Article
- Field Expansion with Multiplexing Prism Glasses Improves Pedestrian Detection for Acquired Monocular Vision.Translational vision science & technology · 2020Article
- Toward Improving the Mobility of Patients with Peripheral Visual Field Defects with Novel Digital Spectacles.American journal of ophthalmology · 2020Article
- Effects of driver compensatory behaviour on risks of critical pedestrian collisions under simulated visual field defects.PloS one · 2020Article
- Design of 45° periscopic visual field expansion device for peripheral field loss.Optics communications · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Patients with peripheral field loss complain of colliding with other pedestrians in open-space environments such as shopping malls. Field expansion devices (e.g., prisms) can create artificial peripheral islands of vision. We investigated the visual angle at which these islands can be most effective for avoiding pedestrian collisions, by modeling the collision risk density as a function of bearing angle of pedestrians relative to the patient. Pedestrians at all possible locations were assumed to be moving in all directions with equal probability within a reasonable range of walking speeds. The risk density was found to be highly anisotropic. It peaked at ≈45° eccentricity. Increasing pedestrian speed range shifted the risk to higher eccentricities. The risk density is independent of time to collision. The model results were compared to the binocular residual peripheral island locations of 42 patients with forms of retinitis pigmentosa. The natural residual island prevalence also peaked nasally at about 45° but temporally at about 75°. This asymmetry resulted in a complementary coverage of the binocular field of view. Natural residual binocular island eccentricities seem well matched to the collision-risk density function, optimizing detection of other walking pedestrians (nasally) and of faster hazards (temporally). Field expansion prism devices will be most effective if they can create artificial peripheral islands at about 45° eccentricities. The collision risk and residual island findings raise interesting questions about normal visual development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.